Kedar Gc

Kedar GC is a Senior Scientist at Ambrx, with a focus on antibody engineering, protein therapeutics, vector design, and optimization of expression systems since June 2014. Prior roles include Scientist II and Scientist, contributing to immuno-oncology programs through advanced antibody engineering techniques on various formats. Kedar has previous experience as a Scientist at Verdezyne, Inc., where responsibilities included metabolic engineering in yeast and Candida for renewable chemicals. Kedar also served as a Staff Scientist at Trius Therapeutics, specializing in antibacterial discovery programs and strain engineering, and held roles at RX3 Pharmaceuticals and Elitra Pharmaceuticals, focusing on microbiological assays and target gene validation. Kedar holds an M.S. in Biology with a concentration in Molecular Biology from San Diego State University.